Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies

被引:1
作者
Wang, Minkun [1 ,2 ]
Tsai, Tsung-Heng [1 ]
Di Poto, Cristina [1 ]
Ferrarini, Alessia [1 ]
Yu, Guoqiang [2 ]
Ressom, Habtom W. [1 ]
机构
[1] Georgetown Univ, Dept Oncol, 4000 Reservoir Rd NW, Washington, DC 20057 USA
[2] Virginia Tech, Dept Elect & Comp Engn, 900 N Glebe Rd, Arlington, VA USA
来源
BMC GENOMICS | 2016年 / 17卷
关键词
Bayesian inference; Topic model; Purification; LC-MS; GC-MS; Extracted ion chromatogram; Metabolomics; Proteomics; Biomarker discovery; IDENTIFICATION; PROTEOMICS; PROFILES;
D O I
10.1186/s12864-016-2796-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: A fundamental challenge in quantitation of biomolecules for cancer biomarker discovery is owing to the heterogeneous nature of human biospecimens. Although this issue has been a subject of discussion in cancer genomic studies, it has not yet been rigorously investigated in mass spectrometry based proteomic and metabolomic studies. Purification of mass spectometric data is highly desired prior to subsequent analysis, e.g., quantitative comparison of the abundance of biomolecules in biological samples. Methods: We investigated topic models to computationally analyze mass spectrometric data considering both integrated peak intensities and scan-level features, i.e., extracted ion chromatograms (EICs). Probabilistic generative models enable flexible representation in data structure and infer sample-specific pure resources. Scan-level modeling helps alleviate information loss during data preprocessing. We evaluated the capability of the proposed models in capturing mixture proportions of contaminants and cancer profiles on LC-MS based serum proteomic and GC-MS based tissue metabolomic datasets acquired from patients with hepatocellular carcinoma (HCC) and liver cirrhosis as well as synthetic data we generated based on the serum proteomic data. Results: The results we obtained by analysis of the synthetic data demonstrated that both intensity-level and scan-level purification models can accurately infer the mixture proportions and the underlying true cancerous sources with small average error ratios (< 7 %) between estimation and ground truth. By applying the topic model-based purification to mass spectrometric data, we found more proteins and metabolites with significant changes between HCC cases and cirrhotic controls. Candidate biomarkers selected after purification yielded biologically meaningful pathway analysis results and improved disease discrimination power in terms of the area under ROC curve compared to the results found prior to purification. Conclusions: We investigated topic model-based inference methods to computationally address the heterogeneity issue in samples analyzed by LC/GC-MS. We observed that incorporation of scan-level features have the potential to lead to more accurate purification results by alleviating the loss in information as a result of integrating peaks. We believe cancer biomarker discovery studies that use mass spectrometric analysis of human biospecimens can greatly benefit from topic model-based purification of the data prior to statistical and pathway analyses.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies
    Minkun Wang
    Tsung-Heng Tsai
    Cristina Di Poto
    Alessia Ferrarini
    Guoqiang Yu
    Habtom W. Ressom
    BMC Genomics, 17
  • [2] Mass spectrometric protein maps for biomarker discovery and clinical research
    Liu, Yansheng
    Huettenhain, Ruth
    Collins, Ben
    Aebersold, Ruedi
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (08) : 811 - 825
  • [3] Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens
    Polyakova, Anna
    Kuznetsova, Ksenia
    Moshkovskii, Sergei
    EXPERT REVIEW OF PROTEOMICS, 2015, 12 (05) : 533 - 541
  • [4] Mass spectrometry-based membrane proteomics in cancer biomarker discovery
    Mermelekas, George
    Zoidakis, Jerome
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (05) : 549 - 563
  • [5] Bioinformatic Analysis of Data Generated from MALDI Mass Spectrometry for Biomarker Discovery
    He, Zengyou
    Qi, Robert Z.
    Yu, Weichuan
    APPLICATIONS OF MALDI-TOF SPECTROSCOPY, 2013, 331 : 193 - 209
  • [6] Biomarker discovery by imperialist competitive algorithm in mass spectrometry data for ovarian cancer prediction
    Pirhadi, Shiva
    Maghooli, Keivan
    Moteghaed, Niloofar Yousefi
    Garshasbi, Masoud
    Mousavirad, Seyed Jalaleddin
    JOURNAL OF MEDICAL SIGNALS & SENSORS, 2021, 11 (02): : 108 - 119
  • [7] MASS SPECTROMETRY-BASED PROTEOMICS: THE ROAD TO LUNG CANCER BIOMARKER DISCOVERY
    Indovina, Paola
    Marcelli, Eleonora
    Pentimalli, Francesca
    Tanganelli, Piero
    Tarro, Giulio
    Giordano, Antonio
    MASS SPECTROMETRY REVIEWS, 2013, 32 (02) : 129 - 142
  • [8] Mass spectrometry-based tissue proteomics for cancer biomarker discovery
    Baigley, Brian M.
    Wang, Weijie
    De Voe, Don L.
    Lee, Cheng S.
    PERSONALIZED MEDICINE, 2007, 4 (01) : 45 - 58
  • [9] Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
    Lu, Ming
    Faull, Kym F.
    Whitelegge, Julian P.
    He, Jianbo
    Shen, Dejun
    Saxton, Romaine E.
    Chang, Helena R.
    BIOMARKER INSIGHTS, 2007, 2 : 347 - 360
  • [10] Protein mass spectra data analysis for clinical biomarker discovery: a global review
    Roy, Pascal
    Truntzer, Caroline
    Maucort-Boulch, Delphine
    Jouve, Thomas
    Molinari, Nicolas
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (02) : 176 - 186